Potential Role of Intravenous Lidocaine Versus Intravenous Ketamine for Pain Management in Fibromyalgia Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 2, 2023

Primary Completion Date

February 29, 2024

Study Completion Date

March 31, 2024

Conditions
Anesthesia
Interventions
DRUG

Lidocaine group

Group A: Lidocaine group( 25 patients) will receive 5 mg/Kg lidocaine in 100 ml normal saline given in 40 minutes with 20 minutes follow up to obverse any delayed complication. This procedure will be repeated weekly for 3 weeks.

DRUG

Ketamine group

Group B:Ketamine group(25 patients) will receive 0.5 mg/Kg ketamine sulphate in 100 ml normal saline given in 40 minutes with 20 minutes follow up to obverse any delayed complication. This procedure will be repeated weekly for 3 weeks.

DRUG

Placebo group

Group C:placebo group (25 patients) will receive placebo 100 ml normal saline given in 40 minutes with 20 minutes follow up to obverse any delayed complication. This procedure will be repeated weekly for 3 weeks

Trial Locations (1)

11721

RECRUITING

maha sadek El Derh, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER